cobas Factor II and Factor V Test— 510(k) K172913

Substantially Equivalent

Roche Molecular Systems, Inc.

FDA 510(k) clearance K172913 for cobas Factor II and Factor V Test, Substantially Equivalent on 2018-01-12. Applicant: Roche Molecular Systems, Inc..

Clearance details

Applicant
Roche Molecular Systems, Inc.
Product code
Code NPR
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Pleasanton, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.